3Sharaikhaneh A, Velamuri S, Badmaev V, et al. The potential role of nat- ural agents in treatment of airway inflammation. Ther Adv Respir Dis, 2007,1 : 105-120.
5David V,Katkin JP.Chronic and recurrent pneumonias in children.Semin Respia Infect,2002,17 (1):72-84.
6British Thoracic Seciety Standards of Care Committee.BTS Guideline for the management of community acquired pneumonia in childhood.Thorax,2002,57(suppll):S11.
7Ollensehlager G, Kopp I, Lelgemann M. The German Program for Disease Management Guidelines: COPD Guideline 2006. Med Klin(Munich) ,2007,102( 1 ) :50-55.
8American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventila- tor-associated,and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine,2005,22:105-106.
9Sharafkhaneh A, Velamuri S, Badmaev V, et al. The potential role of nat- ural agents in treatment of airway inflammation. Ther Adv Respir Dis, 2007,31:105-120.
